IP Lab February 19, 2009

Generics' envy, Patent owner's pride: Roche's 'Valcyte' triumphs at the Chennai Patent Office

Dear All,

On January 1, 2005, the product patent regime in India was born again. In these few years of product patent regime, the Indian pharmaceutical industry has witnessed some tough battles in Indian courts and the four Patent Offices, between MNC patent holders and Indian generic drug manufacturers.

Roche’s drug “Valcyte” (Valganciclovir hydrochloride) too has faced legal challenges. It met its pre-grant stage challenge in which it recently tasted victory at Chennai Patent Office, and is now facing post grant challenge. Roche has instituted infringement action against Cipla and is awaiting its hearing.

Please click here for the document tracing the journey of Valcyte in India and the hurdles it has met and will meet to survive as a valid patent in India.

IP-Pharma Team
Aditi Nadkarni / Gowree Gokhale

Mission and Vision

Distinctly Different


NDA cCep: Upcoming Programs
April 06, 2020


NASSCOM HR Forum: An interactive workshop on "The Code on Wages 2019"
February 25, 2020

This event is over. For event material please click here

Round Table

Indian Infrastructure Sector – Decoding InvITs
November 14, 2019

This event is over. For event material please click here

Want to work with us?


Inviting Top Talent for our Corporate Law, Infrastructure, IP and International Tax Practices

Strong credentials in Corporate Law (in particular M&A or Fund Investment), Infrastructure, IP or International Tax? Now’s the time to apply. We’re looking for the industry's best talent with scope to do extraordinary work for the world’s best, marquee clients. Reach out for a great career in a great place!

Write to happiness(at)nishithdesai.com



Nishith Desai Associates 2013. All rights reserved.